D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 104 Citations 42,319 512 World Ranking 3192 National Ranking 1826

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

The scientist’s investigation covers issues in Internal medicine, Acute kidney injury, Kidney disease, Surgery and Creatinine. His study in Acute kidney injury is interdisciplinary in nature, drawing from both Renal function, Intensive care medicine, Biomarker, Prospective cohort study and Risk factor. His work focuses on many connections between Renal function and other disciplines, such as Myocardial infarction, that overlap with his field of interest in Nephropathy.

His Kidney disease research integrates issues from Clinical trial, Mortality rate, Randomized controlled trial, Disease and Severity of illness. In his work, Risk of mortality and Predictive value of tests is strongly intertwined with Gastroenterology, which is a subfield of Surgery. The Creatinine study combines topics in areas such as Urology, Acute tubular necrosis, Confidence interval, Urine and Cardiac surgery.

His most cited work include:

  • Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. (1106 citations)
  • Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis (747 citations)
  • Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis (747 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Acute kidney injury, Kidney disease, Renal function and Creatinine. His Internal medicine research incorporates themes from Surgery and Cardiology. Chirag R. Parikh interconnects Intensive care medicine, Perioperative, Cardiac surgery, Dialysis and Cohort in the investigation of issues within Acute kidney injury.

His research integrates issues of Proteinuria, Proportional hazards model, Immunology and Risk factor in his study of Kidney disease. His Renal function study combines topics from a wide range of disciplines, such as Hazard ratio, Kidney and Urology. His work deals with themes such as Gastroenterology, Urinary system, Urine and Acute tubular necrosis, which intersect with Creatinine.

He most often published in these fields:

  • Internal medicine (76.72%)
  • Acute kidney injury (59.83%)
  • Kidney disease (37.76%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (76.72%)
  • Acute kidney injury (59.83%)
  • Kidney disease (37.76%)

In recent papers he was focusing on the following fields of study:

Chirag R. Parikh focuses on Internal medicine, Acute kidney injury, Kidney disease, Biomarker and Kidney. His Nephrology, Prospective cohort study, Cardiac surgery, Hazard ratio and Interquartile range study are his primary interests in Internal medicine. His Acute kidney injury study integrates concerns from other disciplines, such as Randomized controlled trial, Intensive care medicine, Creatinine, Dialysis and Cohort.

Chirag R. Parikh interconnects Urinary system, Proteinuria, Biopsy and Renal function in the investigation of issues within Kidney disease. His work in Biomarker addresses subjects such as Cohort study, which are connected to disciplines such as Clinical endpoint. His Kidney research includes themes of Incidence, Transplantation and Urology.

Between 2017 and 2021, his most popular works were:

  • Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US (218 citations)
  • Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. (89 citations)
  • News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document. (60 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Chirag R. Parikh spends much of his time researching Internal medicine, Kidney disease, Acute kidney injury, Renal function and Biomarker. Chirag R. Parikh frequently studies issues relating to Gastroenterology and Internal medicine. His research integrates issues of Nephrology, Blood pressure, Urinary system, Creatinine and Proteinuria in his study of Kidney disease.

Creatinine connects with themes related to Intensive care medicine in his study. The study incorporates disciplines such as Placebo, Dialysis, Randomized controlled trial and Donor selection in addition to Acute kidney injury. His Renal function research is multidisciplinary, relying on both Urine, Kidney, Proportional hazards model and Urology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis.

Steven G. Coca;Swathi Singanamala;Chirag R. Parikh.
Kidney International (2012)

1468 Citations

Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis

Steven G. Coca;Bushra Yusuf;Bushra Yusuf;Michael G. Shlipak;Michael G. Shlipak;Amit X. Garg.
American Journal of Kidney Diseases (2009)

999 Citations

Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review

S.G. Coca;S.G. Coca;R. Yalavarthy;J. Concato;J. Concato;C.R. Parikh;C.R. Parikh.
Kidney International (2008)

818 Citations

Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery.

C.R. Parikh;J. Mishra;H. Thiessen-Philbrook;B. Dursun.
Kidney International (2006)

761 Citations

Urine IL-18 Is an Early Diagnostic Marker for Acute Kidney Injury and Predicts Mortality in the Intensive Care Unit

Chirag R. Parikh;Edward Abraham;Marek Ancukiewicz;Charles L. Edelstein.
Journal of The American Society of Nephrology (2005)

672 Citations

Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis

Xiaolei Zhu;Shenhong Wu;William L. Dahut;Chirag R. Parikh.
American Journal of Kidney Diseases (2007)

667 Citations

Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis

Sri G. Yarlagadda;Steven G. Coca;Richard N. Formica;Emilio D. Poggio.
Nephrology Dialysis Transplantation (2008)

652 Citations

Urinary interleukin-18 is a marker of human acute tubular necrosis.

Chirag R. Parikh;Alkesh Jani;Vyacheslav Y. Melnikov;Sarah Faubel.
American Journal of Kidney Diseases (2004)

640 Citations

Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation.

C. R. Parikh;A. Jani;J. Mishra;Q. Ma.
American Journal of Transplantation (2006)

607 Citations

Acute kidney injury in cirrhosis

Guadalupe Garcia-Tsao;Chirag R. Parikh;Antonella Viola;Antonella Viola.
Hepatology (2008)

579 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Chirag R. Parikh

John A. Kellum

John A. Kellum

University of Pittsburgh

Publications: 156

Amit X. Garg

Amit X. Garg

University of Western Ontario

Publications: 155

Claudio Ronco

Claudio Ronco

University of Padua

Publications: 142

Rinaldo Bellomo

Rinaldo Bellomo

University of Melbourne

Publications: 134

Stuart L. Goldstein

Stuart L. Goldstein

Cincinnati Children's Hospital Medical Center

Publications: 117

Prasad Devarajan

Prasad Devarajan

Cincinnati Children's Hospital Medical Center

Publications: 115

Sean M. Bagshaw

Sean M. Bagshaw

University of Alberta

Publications: 98

Ravindra L. Mehta

Ravindra L. Mehta

University of California, San Diego

Publications: 82

Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh

University of California, Irvine

Publications: 80

Joseph V. Bonventre

Joseph V. Bonventre

Brigham and Women's Hospital

Publications: 75

Csaba P. Kovesdy

Csaba P. Kovesdy

University of Tennessee Health Science Center

Publications: 61

Eric Hoste

Eric Hoste

Ghent University Hospital

Publications: 60

Dorry L. Segev

Dorry L. Segev

Johns Hopkins University

Publications: 54

Chi-yuan Hsu

Chi-yuan Hsu

University of California, San Francisco

Publications: 53

Mark A. Perazella

Mark A. Perazella

Yale University

Publications: 48

Michael G. Shlipak

Michael G. Shlipak

University of California, San Francisco

Publications: 48

Trending Scientists

Philip Resnik

Philip Resnik

University of Maryland, College Park

Matti Rossi

Matti Rossi

Aalto University

Til Schuermann

Til Schuermann

Oliver Wyman

Jianbo Lu

Jianbo Lu

Ford Motor Company (United States)

H. S. Udaykumar

H. S. Udaykumar

University of Iowa

John A. Hibner

John A. Hibner

Johnson & Johnson (United States)

Zhenyu Li

Zhenyu Li

University of Science and Technology of China

Thomas E. Johnson

Thomas E. Johnson

University of Colorado Boulder

Mauro Krampera

Mauro Krampera

University of Verona

Richard Béliveau

Richard Béliveau

University of Quebec at Montreal

James L. Mills

James L. Mills

National Institutes of Health

Vincenzo Savarino

Vincenzo Savarino

University of Genoa

Amy L. Baylor

Amy L. Baylor

National Science Foundation

Carol Padden

Carol Padden

University of California, San Diego

Riccardo Giacconi

Riccardo Giacconi

Johns Hopkins University

Arnold O. Benz

Arnold O. Benz

ETH Zurich

Something went wrong. Please try again later.